FDC
Fdc Limited (NSE: FDC) Q1 FY27 Results: PAT Up 9.2%, Revenue Grows 3%
FDC Limited (NSE: FDC) announces Q1 FY27 results with a 9.2% PAT increase and 3% revenue growth, driven by international formulations.
FDC Limited (NSE: FDC) today announced its unaudited financial results for the first quarter ended June 30, 2026. The company reported consolidated revenue from operations for Q1 FY27 at Rs. 668 crores, marking a Y-o-Y increase of 3.0% compared to Rs. 648 crores in Q1 FY26. The profit after tax (PAT) for the quarter increased by 9.2% Y-o-Y to Rs. 132 crores, while earnings per share (EPS) stood at Rs. 8.14, up from Rs. 7.45 in Q1 FY26.
Revenue Growth Driven by International Formulations
The growth was primarily supported by the performance of International Formulations, particularly the US business. Domestic Formulations and APIs remained relatively muted during the quarter. EBITDA for Q1 FY27 stood at Rs. 143 crores, compared with Rs. 140 crores in Q1 FY26, reflecting Y-o-Y growth of 1.9%.
Segment-wise Performance
Domestic Formulations revenue stood at Rs. 569 crores in Q1 FY27, reflecting a Y-o-Y decline of 1.9%. International Formulations sales stood at Rs. 73 crores in Q1 FY27, registering Y-o-Y growth of 74.2%. The US business reported revenue of Rs. 34 crores, representing Y-o-Y growth of 118.4%. The API business recorded sales of Rs. 24 crores in Q1 FY27, reflecting a Y-o-Y decline of 2.9%.
As a result, FDC Limited’s consolidated financial performance for Q1 FY27 demonstrates a strong foundation for future growth, driven by strategic initiatives and market expansion.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of FDC Limited
FDC Limited belongs to the Healthcare › Drug Manufacturers – Specialty & Generic sector. Here’s a quick read on where the business and the stock stand today.
FDC posts a 3.2% three-month gain, but softens in the last few weeks. Not a single revenue dip or loss quarter in five years — this is a business built to last through cycles. The PEG of 1.70 is mildly rich. Nevertheless, the quality of the business makes it defensible. The stock gives back 10.0% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Revenue grows at 6.9% and profits at 13.2% CAGR — a genuinely strong business. Nevertheless, the stock drops 3.2% in three months. The market sells the stock, not the story. Watch whether that changes at the next earnings. Check Fundamentals of FDC Limited.
FDC
Fdc Limited (FDC) Q4 FY26 Results: PAT Up 167.4%, Revenue Grows 18.9%
FDC Limited (NSE: FDC) announces Q4 FY26 results with PAT up 167.4% and revenue growth of 18.9%. Detailed financial performance and segment analysis.
FDC Limited (NSE: FDC) has announced its financial results for the fourth quarter and year ended March 31, 2026. The company reported a significant surge in its Profit After Tax (PAT) by 167.4% Y-o-Y, driven by robust revenue growth of 18.9% in Q4 FY26.
Revenue and Segment Performance
Q4 FY26 revenue from operations stood at Rs. 585 crore, marking a healthy growth of 18.9% Y-o-Y. The three business segments of Domestic Formulations, Export Formulations, and APIs all achieved healthy growth. Domestic Formulations grew by 8.5%, Export Formulations by 99.3%, and APIs by 38.6%.
EBITDA and Margins
EBITDA for Q4 FY26 stood at Rs. 106 crores, with margins at 18.2% compared to 11.0% last year, driven by enhanced operational efficiencies. The FY26 EBITDA margin improved from 15.4% to 15.9% Y-o-Y, driven by higher gross margin.
Looking Ahead
FDC Limited continues to focus on its strategic growth plans, leveraging its strong operational performance and market presence to drive future growth and profitability. The company remains committed to its vision of making the nation self-reliant in healthcare.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of FDC Limited
FDC Limited belongs to the Healthcare › Drug Manufacturers – Specialty & Generic sector. Here’s a quick read on where the business and the stock stand today.
FDC rises 10.7% over three months, with buying pressure holding steady. The PEG stands at 4.21 — severely stretched. Any earnings miss could trigger a sharp de-rating. Revenue consistency is the one bright spot — zero dips in five years shows operational resilience. RSI hits 73, a level that signals the stock runs hot. Notably, buyers drove volume on 17 recent sessions — though at these levels, some profit-taking is normal. The stock rises 10.7% in three months on 11.4% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of FDC Limited.
-
Basic Materials3 days agoThe Ramco Cements Limited (ramcocem) Wins Three Honours at Kyoorius Design Awards 2026
-
GAIL3 days agoGail (india) Limited Appoints Shri Manoj Kumar Sharma as Director (projects)
-
Basic Materials3 days agoSteel Authority of India Limited (sail) FY’27 Snapshot: Robust Financials and Production Metrics
-
COFORGE2 days agoCoforge Limited (NSE: Coforge) Expands Ai-powered Vehicle Lifecycle Intelligence Capabilities
-
Industrials3 days agoTirupati Forge Limited Secures Strategic Industrial License Under Indian Arms Act for Artillery Shell Manufacturing
-
GODREJPROP3 days agoGodrej Properties Limited (godrejprop) Constructs 24-metre-wide Government Road in Gurugram
-
PREMIERENE1 day agoPremier Energies Limited (premierene) Commissions India’s Largest Solar Cell Facility
-
Information Technology Services22 hours agoPersistent Systems Limited (persistent) Earns Databricks Brickbuilder Specialization for BFSI